Literature DB >> 32380032

Presynaptic Homeostasis Opposes Disease Progression in Mouse Models of ALS-Like Degeneration: Evidence for Homeostatic Neuroprotection.

Brian O Orr1, Anna G Hauswirth1, Barbara Celona2, Richard D Fetter1, Giulia Zunino1, Evgeny Z Kvon3, Yiwen Zhu3, Len A Pennacchio4, Brian L Black2, Graeme W Davis5.   

Abstract

Progressive synapse loss is an inevitable and insidious part of age-related neurodegenerative disease. Typically, synapse loss precedes symptoms of cognitive and motor decline. This suggests the existence of compensatory mechanisms that can temporarily counteract the effects of ongoing neurodegeneration. Here, we demonstrate that presynaptic homeostatic plasticity (PHP) is induced at degenerating neuromuscular junctions, mediated by an evolutionarily conserved activity of presynaptic ENaC channels in both Drosophila and mouse. To assess the consequence of eliminating PHP in a mouse model of ALS-like degeneration, we generated a motoneuron-specific deletion of Scnn1a, encoding the ENaC channel alpha subunit. We show that Scnn1a is essential for PHP without adversely affecting baseline neural function or lifespan. However, Scnn1a knockout in a degeneration-causing mutant background accelerated motoneuron loss and disease progression to twice the rate observed in littermate controls with intact PHP. We propose a model of neuroprotective homeostatic plasticity, extending organismal lifespan and health span.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyotrophic Lateral Sclerosis; ENaC; NMJ; astrocyte; benzamil; homeostatic plasticity; neurodegeneration; neuroprotection; presynaptic release; spinal cord

Mesh:

Substances:

Year:  2020        PMID: 32380032      PMCID: PMC7529479          DOI: 10.1016/j.neuron.2020.04.009

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  75 in total

1.  A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III).

Authors: 
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

2.  Role of Munc18-1 in synaptic plasticity at the myasthenic neuromuscular junction.

Authors:  M S Sons; M Verhage; J J Plomp
Journal:  Ann N Y Acad Sci       Date:  2003-09       Impact factor: 5.691

3.  Reversible Recruitment of a Homeostatic Reserve Pool of Synaptic Vesicles Underlies Rapid Homeostatic Plasticity of Quantal Content.

Authors:  Xueyong Wang; Martin J Pinter; Mark M Rich
Journal:  J Neurosci       Date:  2016-01-20       Impact factor: 6.167

4.  Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.

Authors:  Elsa Tremblay; Éric Martineau; Richard Robitaille
Journal:  J Neurosci       Date:  2017-08-11       Impact factor: 6.167

5.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

6.  TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration.

Authors:  Iga Wegorzewska; Shaughn Bell; Nigel J Cairns; Timothy M Miller; Robert H Baloh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-15       Impact factor: 11.205

7.  Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis.

Authors:  Dara Ditsworth; Marcus Maldonado; Melissa McAlonis-Downes; Shuying Sun; Amanda Seelman; Kevin Drenner; Eveline Arnold; Shuo-Chien Ling; Donald Pizzo; John Ravits; Don W Cleveland; Sandrine Da Cruz
Journal:  Acta Neuropathol       Date:  2017-03-29       Impact factor: 17.088

Review 8.  ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?

Authors:  Dmitry Petrov; Colin Mansfield; Alain Moussy; Olivier Hermine
Journal:  Front Aging Neurosci       Date:  2017-03-22       Impact factor: 5.750

9.  Yeast genetic screen reveals novel therapeutic strategy for ALS.

Authors:  Matthew D Figley; Aaron D Gitler
Journal:  Rare Dis       Date:  2013-03-27

10.  Novel mechanisms for crotonaldehyde-induced lung edema.

Authors:  Yue Li; Jianjun Chang; Yong Cui; Runzhen Zhao; Yan Ding; Yapeng Hou; Zhiyu Zhou; Hong-Long Ji; Hongguang Nie
Journal:  Oncotarget       Date:  2017-05-12
View more
  10 in total

1.  The auxiliary glutamate receptor subunit dSol-1 promotes presynaptic neurotransmitter release and homeostatic potentiation.

Authors:  Beril Kiragasi; Pragya Goel; Sarah Perry; Yifu Han; Xiling Li; Dion Dickman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-24       Impact factor: 11.205

2.  The E3 ligase Thin controls homeostatic plasticity through neurotransmitter release repression.

Authors:  Martin Baccino-Calace; Katharina Schmidt; Martin Müller
Journal:  Elife       Date:  2022-07-07       Impact factor: 8.713

Review 3.  Singling out motor neurons in the age of single-cell transcriptomics.

Authors:  Jacob A Blum; Aaron D Gitler
Journal:  Trends Genet       Date:  2022-04-26       Impact factor: 11.821

4.  A Quantitative Model of Sporadic Axonal Degeneration in the Drosophila Visual System.

Authors:  Mélisande Richard; Karolína Doubková; Yohei Nitta; Hiroki Kawai; Atsushi Sugie; Gaia Tavosanis
Journal:  J Neurosci       Date:  2022-05-09       Impact factor: 6.709

5.  Neuronal and Synaptic Plasticity in the Visual Thalamus in Mouse Models of Glaucoma.

Authors:  Matthew J Van Hook; Corrine Monaco; Elizabeth R Bierlein; Jennie C Smith
Journal:  Front Cell Neurosci       Date:  2021-01-15       Impact factor: 5.505

6.  Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology.

Authors:  Léa M D Wenger; Yu Sun; Kornélia Szebényi; Alexander W E Dunn; Colleen A Limegrover; George M Gibbons; Elena Conci; Ole Paulsen; Susanna B Mierau; Gabriel Balmus; András Lakatos
Journal:  Nat Neurosci       Date:  2021-10-21       Impact factor: 24.884

7.  Extracellular Protons Mediate Presynaptic Homeostatic Potentiation at the Mouse Neuromuscular Junction.

Authors:  Yiyang Zhu; Claire I C Warrenfelt; Jill C Flannery; Clark A Lindgren
Journal:  Neuroscience       Date:  2021-05-21       Impact factor: 3.708

Review 8.  Friend or Foe? The Varied Faces of Homeostatic Synaptic Plasticity in Neurodegenerative Disease.

Authors:  Henry B C Taylor; Alexander F Jeans
Journal:  Front Cell Neurosci       Date:  2021-12-10       Impact factor: 5.505

9.  Mitochondrial dysregulation occurs early in ALS motor cortex with TDP-43 pathology and suggests maintaining NAD+ balance as a therapeutic strategy.

Authors:  Mukesh Gautam; Aksu Gunay; Navdeep S Chandel; P Hande Ozdinler
Journal:  Sci Rep       Date:  2022-03-11       Impact factor: 4.379

10.  Elimination of glutamatergic transmission from Hb9 interneurons does not impact treadmill locomotion.

Authors:  Lina M Koronfel; Kevin C Kanning; Angelita Alcos; Christopher E Henderson; Robert M Brownstone
Journal:  Sci Rep       Date:  2021-08-06       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.